News
BNGOW
0.0036
0.00%
0.00
Weekly Report: what happened at BNGO last week (0608-0612)?
Weekly Report · 1d ago
Bionano says 13 studies back optical genome mapping in reproductive health, prenatal disorder research
PUBT · 5d ago
Weekly Report: what happened at BNGO last week (0601-0605)?
Weekly Report · 06/08 09:00
BioNano Genomics Announces Resignation of Chief Medical Officer
TipRanks · 06/05 21:21
Weekly Report: what happened at BNGO last week (0525-0529)?
Weekly Report · 06/01 09:00
Analysts Offer Insights on Healthcare Companies: BioNano Genomics (BNGO) and BioLife Solutions (BLFS)
TipRanks · 05/29 19:00
BioNano Genomics Retires Secured Debt, Boosts Flexibility
TipRanks · 05/28 12:40
BIONANO ANNOUNCES FULL RETIREMENT OF OUTSTANDING SENIOR SECURED CONVERTIBLE DEBENTURES
Reuters · 05/28 12:00
Bionano Genomics announces OGM study of T-cell acute lymphoblastic leukemia
TipRanks · 05/26 15:31
Bionano says optical genome mapping detects abnormalities in 97.8% of T-ALL cases in largest study to date
PUBT · 05/26 12:03
BIONANO ANNOUNCES LARGEST OGM STUDY OF T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
Reuters · 05/26 12:00
Weekly Report: what happened at BNGO last week (0518-0522)?
Weekly Report · 05/25 09:00
Weekly Report: what happened at BNGO last week (0511-0515)?
Weekly Report · 05/18 09:00
Bionano Genomics Earnings Call: Growth Amid Cash Burn
TipRanks · 05/15 00:22
BioNano Genomics Stockholders Approve 2026 Annual Meeting Proposals
TipRanks · 05/14 21:41
Bionano outlines $30M-$33M 2026 revenue guidance as it expects flow cell supply to improve
Seeking Alpha · 05/13 23:01
Transcript: Bionano Genomics Q1 2026 Earnings Conference Call
Benzinga · 05/13 21:10
Bionano Genomics Q1 revenue up 4%, margin improves; to retire convertible debt
Reuters · 05/13 20:23
Bionano Genomics reports Q1 results
Seeking Alpha · 05/13 20:09
*Bionano Genomics 1Q Loss $8.3M >BNGO
Dow Jones · 05/13 20:09
More
Webull provides a variety of real-time BNGOW stock news. You can receive the latest news about Bionano Genomics through multiple platforms. This information may help you make smarter investment decisions.
About BNGOW
Bionano Genomics, Inc. is a provider of genome analysis solutions that can enable researchers and clinicians to reveal answers to challenging questions in biology and medicine. The Company offers optical genome mapping (OGM) solutions for applications across basic, translational and clinical research. It also offers a platform-agnostic software solution, which integrates sequencing and microarray data designed to provide analysis, visualization, interpretation and reporting of copy number variants, single-nucleotide variants, and absence of heterozygosity across the genome in one consolidated view. The Company additionally offers nucleic acid extraction and purification solutions using proprietary isotachophoresis (ITP) technology. The Company markets and sells OGM systems, including the Saphyr system, which delivers OGM data to enable ultra-sensitive and ultra-specific detection of all classes of structural variation (SV).